Despite being approved for use by the FDA in 2019, many questions remain on the safety, tolerability, and efficacy of ubrogepant in certain patient populations with migraine in the real-world population....
New research investigated the nervous system cell types in which putative migraine-associated genes are expressed. Lead author William Renthal, MD, PhD, answers our questions about this research.
Yiheng Tu, PhD, from Massachusetts General Hospital, answers our questions about innovations in migraine research, a topic he spoke about at the 2019 Migraine Symposium.
